Evolent Health, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
February 23, 2024 at 02:40 am IST
Share
Evolent Health, Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 556.06 million compared to USD 382.43 million a year ago. Net loss was USD 33.41 million compared to USD 11.35 million a year ago. Basic loss per share from continuing operations was USD 0.36 compared to USD 0.11 a year ago.
For the full year, sales was USD 1,963.9 million compared to USD 1,352.01 million a year ago. Net loss was USD 113.04 million compared to USD 19.16 million a year ago. Basic loss per share from continuing operations was USD 1.28 compared to USD 0.2 a year ago. Basic loss per share was USD 1.28 compared to USD 0.2 a year ago.
Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers three primary solutions: specialty care management services, total cost of care management and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advance care planning services as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.